HomeACXP • NASDAQ
add
Acurx Pharmaceuticals Inc
Previous close
$4.29
Day range
$4.11 - $4.36
Year range
$3.17 - $25.00
Market cap
8.57M USD
Avg Volume
82.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.03M | -28.23% |
Net income | -1.99M | 29.37% |
Net profit margin | — | — |
Earnings per share | -1.23 | 63.82% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.91M | 2.50% |
Total assets | 6.11M | 2.05% |
Total liabilities | 2.47M | -25.63% |
Total equity | 3.64M | — |
Shares outstanding | 2.09M | — |
Price to book | 2.12 | — |
Return on assets | -82.72% | — |
Return on capital | -140.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.99M | 29.37% |
Cash from operations | -1.88M | 14.10% |
Cash from investing | — | — |
Cash from financing | 1.72M | 8.30% |
Net change in cash | -157.33K | 73.70% |
Free cash flow | -1.20M | 4.38% |
About
CEO
Founded
2017
Website
Employees
4
